Nuclear Medicine Concerns

The risks associated with low-level exposure to radiation are still not fully understood but as a general rule, the amount of exposure is kept “As Low As Reasonably Practicable” (ALARP), so that the least amount of radiation is used to achieve results that are still accurate.

The effective radiation dose varies according to the type of study performed. The dose may therefore vary from less than or similar to that of a person’s every day environmental background dose, to a dose that far exceeds it. Similarly, the dose may be less than, similar to or higher than the dose received during a pelvic or abdominal computed tomography (CT) scan.

Sometimes, patients undergoing nuclear medicine procedures require special preparation beforehand if accurate results are to be achieved. For example, certain medications may need to be stopped or a certain diet may need to be followed. Advice is usually provided by the nuclear medicine team about exactly which patient preparations may be required prior to a scan.

For patients undergoing a nuclear medicine analysis, the radiation is generally administered internally. The radiopharmaceutical agent is given to the patient orally or intravenously, as opposed to the application of external beams seen in radiotherapy. The radiopharmaceutical used emits ionizing radiation as it passes through the specific organs or tissues it is attracted to. This targeted radiation only travels a short distance, meaning damage to healthy neighbouring tissues or organs is minimized. Usually, these therapies are performed on an outpatient basis and most patients can go home after therapy.

Further Reading

Last Updated: Jun 12, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 12). Nuclear Medicine Concerns. News-Medical. Retrieved on February 25, 2024 from

  • MLA

    Mandal, Ananya. "Nuclear Medicine Concerns". News-Medical. 25 February 2024. <>.

  • Chicago

    Mandal, Ananya. "Nuclear Medicine Concerns". News-Medical. (accessed February 25, 2024).

  • Harvard

    Mandal, Ananya. 2023. Nuclear Medicine Concerns. News-Medical, viewed 25 February 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients